EDGAR Filing Documents for 0001171843-12-002812

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-12-002812

Filing Date

2012-07-31

Accepted

2012-07-31 11:45:16

Documents

Period of Report

2012-05-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_073012.htm	6-K	20733
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	504109
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	276727
4	EXHIBIT 99.3	exh_993.htm	EX-99.3	9416
5	EXHIBIT 99.4	exh_994.htm	EX-99.4	9661
6	EXHIBIT 99.5	exh_995.htm	EX-99.5	16585
7		logo.gif	GRAPHIC	7105
	Complete submission text file	0001171843-12-002812.txt		848136

Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3

Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)